Trial intelligence / Profile preview

Lidocaine and huffing maneuver to prevent fentanyl-induced cough

IRCT20141009019470N74Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of lidocaine in cough, sponsored by Shiraz University of Medical Sciences. Primary endpoint: Incidence of cough after fentanyl injection. Started Mar 2018; status: completed.

02

Drugs

lidocaine
03

Conditions

cough

Beyond the preview

Go deeper on IRCT20141009019470N74.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141009019470N74.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call